ATOPIC
Clinical trials for ATOPIC explained in plain language.
Never miss a new study
Get alerted when new ATOPIC trials appear
Sign up with your email to follow new studies for ATOPIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug camoteskimab tested for Tough-to-Treat eczema
Disease control CompletedThis study tested a new drug, camoteskimab, in 62 adults with moderate to severe eczema (atopic dermatitis). Participants received either the drug or a placebo for 16 weeks, followed by an open-label extension where everyone could get the drug. The main goal was to see if camotes…
Matched conditions: ATOPIC
Phase: PHASE2 • Sponsor: Apollo Therapeutics Ltd • Aim: Disease control
Last updated Jun 26, 2026 17:44 UTC
-
New pill for Kids' eczema itch shows promise in large trial
Symptom relief CompletedThis study tested whether a new oral medicine called TAU-284 (bepotastine besilate) can reduce itching in children aged 7 to 15 with atopic dermatitis (eczema). Over 300 children took either TAU-284 or an older medicine (ketotifen) twice daily for several weeks. The main goal was…
Matched conditions: ATOPIC
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC